CEACAM5 and neoplasm: Six patients underwent tumor marker examination during follow-up period and the positive rate were as followed: CA-125 83.3% (5/6), CA-199 16.7% (1/6), CEA 0.0% (0/6), AFP 0.0% (0/6).